Floatz logo

Carboplatin

Advanced (Stage IIIB-C-IV) Ovarian, Primary Peritoneal and Fallopian Tube Cancer

AbbVieSmall moleculePhase 2/3Active
BB
68/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
55/ 100
Competitive Position
95/ 100

Competitive context

51 Active assets in the Advanced (Stage IIIB-C-IV) Ovarian, Primary Peritoneal and Fallopian Tube Cancer cohort.

Asset / SponsorPhaseRating
Inno-206
AstraZeneca
Phase 2BB
Indocyanine Green
Istanbul University
Phase 4BB
Ipilimumab
M.D. Anderson Cancer Center
Phase 2B
Nivolumab
Clovis Oncology, Inc.
Phase 2B
Atezolizumab
M.D. Anderson Cancer Center
Phase 2B

View all 50 →

Same molecule, other indications

Carboplatin is also rated in:

lung large cell carcinomaDormant
A
Indicative ·
80 / 100
View asset →
non-small cell squamous lung carcinomaDormant
BBB
Indicative ·
76 / 100
View asset →
primary peritoneal carcinomaDormant
BBB
Indicative ·
76 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →